An anticholinergic medication used to treat parkinson’s disease and to control medication-induced extrapyramidal symptoms (EPS). The brand name kemadrin was discontinued by the manufacturer in 2008, and no generics are currently available.
Drug used to reduce tremor in Parkinsonism and also to control the side effects of antipsychotic medications. Adverse effects include dry mouth, blurred vision, rapid heartbeat, and decreased sweating.
A drug, similar in its effects to atropine, used to reduce muscle tremor and rigidity in parkinsonism. It is administered by mouth or injection; common side-effects include dry mouth, blurred vision, and giddiness.
An anticholinergic medication utilized for Parkinson’s disease treatment. It’s also employed to mitigate the potential side effects of specific antipsychotic drugs. Possible undesired outcomes of procyclidine consist of dry mouth and blurred vision.